|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-9-25
|
|
pubmed:abstractText |
Recent advances in the treatment of hematological malignancies often induce febrile neutropenia (FN) due to severe myelosuppression. The aim of this study was to evaluate the safety and efficacy of biapenem in such FN.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0368-2781
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-21
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:18814798-Adult,
pubmed-meshheading:18814798-Aged,
pubmed-meshheading:18814798-Aged, 80 and over,
pubmed-meshheading:18814798-Anti-Infective Agents,
pubmed-meshheading:18814798-Female,
pubmed-meshheading:18814798-Fever,
pubmed-meshheading:18814798-Humans,
pubmed-meshheading:18814798-Injections, Intravenous,
pubmed-meshheading:18814798-Leukemia, Myeloid, Acute,
pubmed-meshheading:18814798-Lymphoma, Non-Hodgkin,
pubmed-meshheading:18814798-Male,
pubmed-meshheading:18814798-Middle Aged,
pubmed-meshheading:18814798-Multiple Myeloma,
pubmed-meshheading:18814798-Neutropenia,
pubmed-meshheading:18814798-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:18814798-Thienamycins
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Clinical effects of biapenem on febrile neutropenia in patients with hematological malignancy].
|
|
pubmed:affiliation |
First Department of Internal Medicine, Gifu University Graduate School of Medicine.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
